The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Kyverna Therapeutics Inc (NASDAQ: KYTX) closed at $3.31 in the last session, down -8.06% from day before closing price of $3.60. In other words, the price has decreased by -$8.06 from its previous closing price. On the day, 0.62 million shares were traded.
Ratios:
We take a closer look at KYTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.44 and its Current Ratio is at 7.44. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On October 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $13.
On October 09, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.Rodman & Renshaw initiated its Buy rating on October 09, 2024, with a $16 target price.
Stock Price History:
Over the past 52 weeks, KYTX has reached a high of $16.64, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is 43.57%, while the 200-Day Moving Average is calculated to be -14.96%.
Shares Statistics:
A total of 43.22M shares are outstanding, with a floating share count of 19.45M. Insiders hold about 54.98% of the company’s shares, while institutions hold 25.51% stake in the company.
